Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Minoxidil-loaded NLC gel shows potential for effective alopecia treatment.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

Hair transplantation can help transgender patients affirm their gender identity.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

Platelet-rich plasma is considered safe but needs more research to prove its effectiveness in medical treatments.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

A standardized consent form for PRP injections improves patient trust and legal protection.

Hair transplants are effective for male and female pattern baldness, have evolved in technique, and require careful planning for natural results and managing complications.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

New method accurately measures finasteride in tablets and bulk.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

P-3074 effectively blocks scalp DHT better than oral finasteride.

Dutasteride is approved to help manage prostate enlargement.

PRP preparation partially activates platelets, causing varied growth factor release.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

PP405 shows promise as a new, effective treatment for hair loss with minimal side effects.

The method accurately measures Tamsulosin and Finasteride in medication and is suitable for regular quality checks.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Combining PRP with Procapil is more effective for hair loss treatment than PRP alone.

PRP is a safe, effective treatment for tissue regeneration and various skin conditions.

Created microspheres show potential for safe and effective use in prostate artery embolization.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.